George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHargreaves Lansdown Regulatory News (HL.)

Share Price Information for Hargreaves Lansdown (HL.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 755.00
Bid: 754.60
Ask: 755.40
Change: 18.80 (2.55%)
Spread: 0.80 (0.106%)
Open: 753.80
High: 762.00
Low: 743.20
Prev. Close: 736.20
HL. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

7 Mar 2024 13:54

RNS Number : 0430G
Hargreaves Lansdown PLC
07 March 2024
 

Hargreaves Lansdown plc ("the Company")

Director/PDMR/PCA Transaction - Initial Notification

 

The Company announces that Richard Hebdon a director/person discharging managerial responsibility in the Company has been granted nil-cost options over 35,463 ordinary shares in the Company under the Sustained Performance Plan II. The grant took place on Wednesday 06 March 2024.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

Richard Hebdon

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR

b)

 

Initial notification /Amendment

 

INITIAL NOTIFICATION

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

 

HARGREAVES LANSDOWN PLC

b)

 

LEI

 

2138008ZCE93ZDSESG90

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

ORDINARY SHARES

 

GB00B1VZ0M25 

 

b)

 

Nature of the transaction

GRANT OF OPTIONs UNDER sustained performance plan II

c)

 

Price(s) and volume(s)

 

 

 

 Price(s)

Volume(s)

 GBP£ Nil cost

35,463

 d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

Grant of options over 35,463 ordinary shares at nil cost per ordinary share 

e)

 

Date of the transaction

 

 

06 March 2024

f)

 

Place of the transaction

 

 

OUTSIDE A TRADING VENUE

 

 

The nil-cost options will become exercisable on vesting dates shown below, subject to continuous employment with Hargreaves Lansdown plc.

 

Number of shares subject to option

Vesting date

Option price

Arrangement

1,009

27 March 2025

Nil Cost

Listing Rule 9.4.2 arrangement

1,009

27 March 2026

Nil Cost

Listing Rule 9.4.2 arrangement

1,009

27 March 2027

Nil Cost

Listing Rule 9.4.2 arrangement

14,978

06 March 2024

Nil Cost

Listing Rule 9.4.2 arrangement

9,304

14 February 2025

Nil Cost

Listing Rule 9.4.2 arrangement

8,154

20 February 2026

Nil Cost

Listing Rule 9.4.2 arrangement

 

 

Buy-Out Awards

 

The nil-cost options were awarded to Richard Hebdon under an arrangement to which Listing Rule 9.4.2 applies in respect of the buy-out of the share option arrangements Richard Hebdon forfeited on leaving their previous employment. 

 

The Remuneration Committee believes that the award fairly reflects the value of awards Richard Hebdon forfeited on leaving his previous employment in terms of value and timescale of vesting.

 

This announcement is made in accordance with the requirements of DTR 3.1.4.

 

 

 

Claire Chapman

Company Secretary

 

Enquiries:

Danny Cox, Head of Communications (07989 672 071)

James Found, Head of Investor Relations (07970 066 634)

 

Copies of our announcements are available on our website http://www.hl.co.uk/investor-relations/regulatory-announcements 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHXDLFBZXLEBBX
Date   Source Headline
25th Apr 20242:43 pmRNSDirector Declaration
19th Apr 20241:56 pmRNSDirector/PDMR Shareholding
4th Apr 202411:24 amRNSDirector/PDMR Shareholding
7th Mar 20241:54 pmRNSDirector/PDMR Shareholding
28th Feb 20244:01 pmRNSDirector/PDMR Shareholding
27th Feb 20242:29 pmRNSDirector/PDMR Shareholding
26th Feb 20244:43 pmRNSDirector/PDMR Shareholding
23rd Feb 20244:05 pmRNSDirector/PDMR Shareholding
22nd Feb 20247:00 amRNSHalf-year Report
9th Feb 202412:10 pmRNSNotice of Results
6th Feb 202412:08 pmRNSDirectorate Change
1st Feb 20247:09 amRNSDirector Declaration
17th Jan 202412:03 pmRNSDirector Declaration
2nd Jan 202410:06 amRNSDirector Declaration
20th Dec 202312:50 pmRNSDirector/PDMR Shareholding
14th Dec 202312:06 pmRNSDirector Declaration
11th Dec 20237:17 amRNSDirector Declaration
8th Dec 20234:33 pmRNSResult of AGM
6th Dec 20238:10 amRNSDirector Declaration
29th Nov 20237:00 amRNSDirectorate Change
7th Nov 20231:54 pmRNSNotice of AGM
23rd Oct 20238:00 amRNSAnnual Financial Report
19th Oct 20237:00 amRNSTrading Statement
12th Oct 20234:10 pmRNSDirector/PDMR Shareholding
12th Oct 20234:09 pmRNSDirector/PDMR Shareholding
22nd Sep 20233:21 pmRNSDirector/PDMR Shareholding
21st Sep 20234:15 pmRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSFinal Results
1st Sep 20239:59 amRNSNotice of Results
19th Jul 20237:00 amRNSTrading Statement
17th Jul 20234:32 pmRNSDirectorate Change
10th Jul 202311:00 amRNSDirectorate Change
15th Jun 202312:13 pmRNSHolding(s) in Company
13th Jun 20231:00 pmRNSDirectorate Change
15th May 20234:51 pmRNSDirector/PDMR Shareholding
10th May 20234:01 pmRNSDirector/PDMR Shareholding
4th May 202311:00 amRNSDirector Declaration
4th May 20237:00 amRNSTrading Statement
25th Apr 20232:13 pmRNSDirector/PDMR Shareholding
1st Mar 202310:22 amRNSDirector/PDMR Shareholding
15th Feb 20237:00 amRNSHalf-year Report
27th Jan 202312:02 pmRNSDirector Declaration
23rd Jan 202310:10 amRNSNotice of Results
19th Jan 20233:33 pmRNSHolding(s) in Company
20th Dec 20222:01 pmRNSDirector/PDMR Shareholding
16th Dec 202211:05 amRNSDirector Declaration
8th Dec 20228:00 amRNSDirectorate Change
24th Oct 20223:00 pmRNSHolding(s) in Company
19th Oct 20225:16 pmRNSResult of AGM
17th Oct 20227:01 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.